Impact of aging on cancer immunity and immunotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 12
Results: 18
1
2
2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1991, doi. 10.1007/s00262-009-0704-9
- By:
- Publication type:
- Article
3
A genetic variant of immunoglobulin γ2 is strongly associated with immunity to mucin 1 in patients with breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2025, doi. 10.1007/s00262-009-0709-4
- By:
- Publication type:
- Article
4
Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b<sup>+</sup>/CCR3<sup>−</sup>/Gr-1<sup>−</sup> cells cytotoxic against the tumor cells
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2011, doi. 10.1007/s00262-009-0708-5
- By:
- Publication type:
- Article
5
Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2003, doi. 10.1007/s00262-009-0707-6
- By:
- Publication type:
- Article
6
Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2031, doi. 10.1007/s00262-009-0710-y
- By:
- Publication type:
- Article
7
Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2059, doi. 10.1007/s00262-009-0714-7
- By:
- Publication type:
- Article
8
Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2039, doi. 10.1007/s00262-009-0712-9
- By:
- Publication type:
- Article
9
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2051, doi. 10.1007/s00262-009-0713-8
- By:
- Publication type:
- Article
10
The effect of aging on OX40 agonist-mediated cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1941, doi. 10.1007/s00262-009-0687-6
- By:
- Publication type:
- Article
11
Mechanisms of murine dendritic cell antitumor dysfunction in aging.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1935, doi. 10.1007/s00262-008-0636-9
- By:
- Publication type:
- Article
12
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1949, doi. 10.1007/s00262-009-0718-3
- By:
- Publication type:
- Article
13
Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1919, doi. 10.1007/s00262-009-0658-y
- By:
- Publication type:
- Article
14
Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 2073, doi. 10.1007/s00262-009-0715-6
- By:
- Publication type:
- Article
15
Immunosenescence and cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1959, doi. 10.1007/s00262-009-0665-z
- By:
- Publication type:
- Article
16
Cancer, aging and immunotherapy: lessons learned from animal models.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1979, doi. 10.1007/s00262-009-0677-8
- By:
- Publication type:
- Article
17
The importance of the age factor in cancer vaccination at older age.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1969, doi. 10.1007/s00262-009-0683-x
- By:
- Publication type:
- Article
18
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1909, doi. 10.1007/s00262-008-0639-6
- By:
- Publication type:
- Article